Literature DB >> 27714780

Linagliptin-associated bullous pemphigoid that was most likely caused by IgG autoantibodies against the midportion of BP180.

A Sakai1, Y Shimomura1, O Ansai1, Y Saito1, K Tomii1, Y Tsuchida1, H Iwata2, H Ujiie2, H Shimizu2, R Abe1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27714780     DOI： 10.1111/bjd.15111

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  9 in total

1.  Efficacy and safety of tetracyclines for pemphigoid: a systematic review and meta-analysis.

Authors:  Xin-Xing Jin; Xue Wang; Ying Shan; Si-Zhe Li; Qun Xu; Hong-Zhong Jin; Ya-Gang Zuo
Journal:  Arch Dermatol Res       Date:  2021-03-28       Impact factor: 3.017

Review 2.  BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

Authors:  Yale Liu; Liang Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

3.  Bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors: A report of five cases.

Authors:  Satoshi Yoshiji; Takaaki Murakami; Shin-Ichi Harashima; Rie Ko; Riko Kashima; Daisuke Yabe; Masahito Ogura; Kentaro Doi; Nobuya Inagaki
Journal:  J Diabetes Investig       Date:  2017-06-26       Impact factor: 4.232

Review 4.  Bullous Pemphigoid Triggered by Thermal Burn Under Medication With a Dipeptidyl Peptidase-IV Inhibitor: A Case Report and Review of the Literature.

Authors:  Yosuke Mai; Wataru Nishie; Kazumasa Sato; Moeko Hotta; Kentaro Izumi; Kei Ito; Kazuyoshi Hosokawa; Hiroshi Shimizu
Journal:  Front Immunol       Date:  2018-04-12       Impact factor: 7.561

5.  Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients.

Authors:  Olivier Gaudin; Vannina Seta; Marina Alexandre; Gérôme Bohelay; Françoise Aucouturier; Sabine Mignot-Grootenboer; Saskia Ingen-Housz-Oro; Céline Bernardeschi; Pierre Schneider; Benoît Mellottee; Frédéric Caux; Catherine Prost-Squarcioni
Journal:  Front Immunol       Date:  2018-05-24       Impact factor: 7.561

6.  Bullous Pemphigoid Associated with the Dipeptidyl Peptidase-4 Inhibitor Sitagliptin in a Patient with Liver Cirrhosis Complicated with Rapidly Progressive Hepatocellular Carcinoma.

Authors:  Masaru Harada; Akitoshi Yoneda; Sanehito Haruyama; Kei Yabuki; Yuichi Honma; Masaaki Hiura; Michihiko Shibata; Hidehiko Matsuoka; Yasuhiro Uchiwa
Journal:  Intern Med       Date:  2017-08-21       Impact factor: 1.271

Review 7.  Dipeptidyl Peptidase-4 Inhibitor-Associated Bullous Pemphigoid.

Authors:  Kaisa Tasanen; Outi Varpuluoma; Wataru Nishie
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 8.786

8.  Linagliptin-Associated Alopecia and Bullous Pemphigoid.

Authors:  Ali Someili; Khalid Azzam; Mohannad Abu Hilal
Journal:  Eur J Case Rep Intern Med       Date:  2019-09-10

Review 9.  Bullous Pemphigoid: Trigger and Predisposing Factors.

Authors:  Francesco Moro; Luca Fania; Jo Linda Maria Sinagra; Adele Salemme; Giovanni Di Zenzo
Journal:  Biomolecules       Date:  2020-10-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.